ArticleJournal of neurochemistry2025

CXCR2 immunomodulatory therapy protects against microstructural white matter injury and gait abnormalities but does not mitigate deficits of cognition in a preclinical model of cerebral palsy.

Yuma Kitase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.